Dengue Fever
INTRODUCTION
Dengue fever virus is considered
the most important arbovirus in terms of morbidity,
mortality and economic cost with an estimated 100 million
cases of dengue fever occurring throughout the world
annually. Dengue is transmitted by mosquito and occurs in
epidemic and endemic proportions throughout tropical and
subtropical regions of the world. Infection with dengue
virus causes a wide number of clinical symptoms which
range in severity. These include fever, a maculopapular
rash and headache. Primary infection with dengue usually
results in a febrile, self limiting disease, however,
secondary infection may result in severe complications
such as dengue shock syndrome (DSS) or dengue
haemorrhagic fever (DHF). Patients diagnosed with dengue
in endemic areas such as South East Asia generally have
secondary infection, whereas patients in non endemic
areas are usually diagnosed with primary infection.
Characteristic antibody responses to the disease enable
serological diagnosis and differentiation between primary
and secondary dengue.
MORPHOLOGY
- RNA viruses
- belong to family Flaviviridae
- four serotypes (1, 2, 3 and 4)
- different strains within each serotype
PATHOGENESIS
- transmitted by mosquito, principally Aedes
aegypti
- incubation time ranges from 3 to 10 days
CLINICAL
ASPECTS
Primary
Infection
- acute febrile illness of sudden onset
- fever lasting 3 to 5 days
- headache, myalgia, arthralgia or muscular pain,
retro-orbital pain, anorexia
- fine mculopapular rash on extremities
- recovery may be associated with fatigue and
depression
- chidren usually have milder disease than adults
Secondary
Infection
- over 90% of cases of DHF and DSS occur in
patients previously infected with the virus
- symptoms are similar to those seen in primary
infection, although after a period of 3 to 7 days
the patient goes on to display haemorrhagic
symptoms
- bleeding, particularly in skin (petichiae),
occaisionally in gunms and nose
- increased vascular permeability, resulting in
leakage of plasma into extravascular spaces and
which leads to hypovolaemia
- haemorrhagic symptoms
- reduced blood pressure
- vascular changes and coagulopathy
- circulatory shock
- vomiting and abdominal pain
- lymphadenopathy and hepatomegaly may occur
- presence of blood in stools, vomitus, urine
ANTIBODY
RESPONSE
Infection
will result in lifelong immunity to that serotype, but
only temporary immunity to other serotypes
Primary
Infection
- IgM antibodies appear approximately 5 days after
onset of symptoms and rise for
the next 1-3 weeks
- IgM antibodies detectable for up to 6 months
- IgG are detectable at approximately 14 days after
onset of symptoms and are
maintained for life
Secondary
Infection
- pproximately 5% patients do not produce
detectable levels of specific IgM
- IgM titre can be slower to rise in secondary
infection
- IgG appears approximately 2 days after symptoms
appear
- IgG titre significantly higher in secondary
infection
DIAGNOSIS
- may not be diagnosed correctly in endemic areas
due to generalised and non specific clinical
manifestations
- based mainly on serological methods, as this
method is useful in
distinguishing primary from secondary infection
Haemagglutination
Inhibition Assays (HAI)
- traditional method of diagnosis
- sera must be acetone or kaolin treated before
testing
- requires paired sera collected at least 7 days
apart
- variance in potency of haemagglutinins made in
different laboratories
has lead to doubts regarding general
applicability
ELISA
- pre-treatment of sera is not required
- serial dilution not required - diagnosis can be
made from a single serum specimen
- diagnosis can be from a single serum sample
TREATMENT
- No Specific treatment for primary dengue
Secondary
Infection
- intravenous fluid replacement and use of
plasma expanders
- oxygen therapy
- blood transfusions in cases of severe
bleeding
- heparin for severe haemorrhage
REVENTION
- Presently no vaccine for prevention of disease
- interruption of breeding cycles of mosquitoes,
particularly in stagnant water around the home
- use of insect repellent and insecticidal
treatment and spraying
|